E-LIB Suche - Ergebnisse für: Haddad, R I

1

FIERCE-HN: A Multicenter, Randomized, Placebo-controlled, P..:

Bauman, J. ; Allman, K. ; Haddad, R.I.
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e36 , 2024

Link: https://doi.org/10.1016/..

2

Pre- and Post-treatment Serum Cytokine Expression Signature..:

Saif, M.S.I.S. ; Sehgal, K. ; Zhang, Z....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e90 , 2024

Link: https://doi.org/10.1016/..

3

A Phase 2 Clinical Trial of Pembrolizumab with Radiation Fo..:

Schoenfeld, J.D. ; Chen, Y.H. ; Gunasti, L....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e32 , 2024

Link: https://doi.org/10.1016/..

4

Pembrolizumab with or Without Lenvatinib As First-line Ther..:

Licitra, L. ; Tahara, M. ; Harrington, K....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e2-e3 , 2024

Link: https://doi.org/10.1016/..

5

Prospective Study of Plasma Biomarker-Guided Surveillance o..:

Rettig, E.M. ; Miller, J. ; Sargent, B....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e50 , 2024

Link: https://doi.org/10.1016/..

6

XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherap..:

Ferris, R.L. ; Mehanna, H. ; Schoenfeld, J.D....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e17-e18 , 2024

Link: https://doi.org/10.1016/..

7

Zanzalintinib Plus Pembrolizumab Versus Pembrolizumab Alone..:

Saba, N.F. ; Harrington, K. ; Licitra, L....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e40-e41 , 2024

Link: https://doi.org/10.1016/..

8

Automated Sarcopenia Assessment and Outcomes in Head and Ne..:

Saraf, A. ; Ye, Z. ; Likitlersuang, J....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e623 , 2023

Link: https://doi.org/10.1016/..

9

A Phase 2/3, Randomized, Open-Label Study of Bempegaldesleu..:

Seiwert, T.Y. ; Haddad, R.I. ; Johnson, D....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e36-e37 , 2022

Link: https://doi.org/10.1016/..

10

Screening for Extranodal Extension with Deep Learning: Eval..:

Kann, B.H. ; Likitlersuang, J. ; Ye, Z....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S26-S27 , 2022

Link: https://doi.org/10.1016/..

11

Deep Learning and Harmonization of Multi-Institutional Data..:

Plana, D. ; Guntaka, P.K. ; Qian, J.M....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e97-e98 , 2021

Link: https://doi.org/10.1016/..

12

Oligometastatic Adenoid Cystic Carcinoma: Correlating Tumor..:

Tyan, K. ; Bae, J.E. ; Lorch, J....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e415-e416 , 2021

Link: https://doi.org/10.1016/..

13

Neoadjuvant Nivolumab +/- Ipilimumab in Patients with Oral ..:

Schoenfeld, J.D. ; Hanna, G.J. ; Jo, V....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1114 , 2020

Link: https://doi.org/10.1016/..

14

PIK-ing out an intermediate-risk subgroup in advanced adeno..:

Hanna, G.J. ; Bae, J.E. ; Lorch, J....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1192 , 2020

Link: https://doi.org/10.1016/..

15

Chemotherapy outcomes following immunotherapy failure in ad..:

Kacew, A.J. ; Lorch, J. ; Schoenfeld, J.D....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1177-1178 , 2020

Link: https://doi.org/10.1016/..